Literature DB >> 22556320

Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension.

Bart G Boerrigter1, Harm J Bogaard1, Pia Trip1, Herman Groepenhoff1, Heleen Rietema1, Sebastiaan Holverda1, Anco Boonstra1, Pieter E Postmus1, Nico Westerhof2, Anton Vonk-Noordegraaf3.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) is a well-recognized complication of COPD. The impact of PH on exercise tolerance is largely unknown. We evaluated and compared the circulatory and ventilatory profiles during exercise in patients with COPD without PH, with moderate PH, and with severe PH.
METHODS: Forty-seven patients, GOLD (Global Initiative for Chronic Obstructive Lung Disease)stages II to IV, underwent cardiopulmonary exercise testing and right-sided heart catheterization at rest and during exercise. Patients were divided into three groups based on mean pulmonary artery pressure (mPAP) at rest: no PH (mPAP, < 25 mm Hg), moderate PH (mPAP, 25-39 mm Hg),and severe PH (mPAP, ≥ 40 mm Hg). Mixed venous oxygen saturation (S VO 2 ) was used for evaluating the circulatory reserve. Pa CO 2 and the calculated breathing reserve were used for evaluation of the ventilatory reserve.
RESULTS: Patients without PH (n = 24) had an end-exercise S VO 2 of 48%± 9%, an increasing Pa CO 2 with exercise, and a breathing reserve of 22% ± 20%. Patients with moderate PH (n = 14) had an exercise S VO 2 of 40% ± 8%, an increasing Pa CO 2 , and a breathing reserve of 26% ± 15%. Patients with severe PH (n =9) had a significantly lower end-exercise S VO 2 (30% ± 6%), a breathing reserve of 37% ± 11%, and an absence of Pa CO 2 accumulation.
CONCLUSION: Patients with severe PH showed an exhausted circulatory reserve at the end of exercise.A profile of circulatory reserve in combination with ventilatory impairments was found inpatients with COPD and moderate or no PH. The results suggest that pulmonary vasodilation might only improve exercise tolerance in patients with COPD and severe PH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556320     DOI: 10.1378/chest.11-2798

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  34 in total

1.  Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.

Authors:  Lauren Rose; Kurt W Prins; Stephen L Archer; Marc Pritzker; E Kenneth Weir; Jeffrey R Misialek; Thenappan Thenappan
Journal:  J Heart Lung Transplant       Date:  2018-09-14       Impact factor: 10.247

Review 2.  Pulmonary hypertension in chronic obstructive pulmonary disease and emphysema patients: prevalence, therapeutic options and pulmonary circulatory effects of lung volume reduction surgery.

Authors:  Isabelle Opitz; Silvia Ulrich
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

Review 3.  Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options.

Authors:  Stephan Rosenkranz
Journal:  Clin Res Cardiol       Date:  2014-12-06       Impact factor: 5.460

4.  [Cor pulmonale and pulmonary hypertension. Update after the world conference in Nice].

Authors:  S Rosenkranz
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

5.  Taking it to heart: dissecting cardiopulmonary interactions in diseases of the lung and the cardiovascular system.

Authors:  Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-12       Impact factor: 5.464

6.  The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema.

Authors:  Yochai Adir; Jacob E Ollech; Baruch Vainshelboim; Yael Shostak; Arie Laor; Mordechai R Kramer
Journal:  Lung       Date:  2015-03-07       Impact factor: 2.584

Review 7.  Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.

Authors:  Andrea L Frump; Sébastien Bonnet; Vinicio A de Jesus Perez; Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-02       Impact factor: 5.464

8.  Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Xuesong Chen; Shaowen Tang; Kouying Liu; Qinling Li; Hui Kong; Xiaoning Zeng; Weiping Xie; Hong Wang
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

Review 9.  [Functional diagnostics in pneumology].

Authors:  M Held; S Baron; B Jany
Journal:  Internist (Berl)       Date:  2018-01       Impact factor: 0.743

Review 10.  Obstructive Ventilatory Disorder in Heart Failure-Caused by the Heart or the Lung?

Authors:  Sergio Caravita; Jean-Luc Vachiéry
Journal:  Curr Heart Fail Rep       Date:  2016-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.